2019
DOI: 10.1007/978-3-030-22744-9_5
|View full text |Cite
|
Sign up to set email alerts
|

An Approach for Semantic Data Integration in Cancer Studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…It is Implemented upon the Ontop platform 39 and built a data integration pipeline to query, extract, and transform data in relational databases using semantic queries into a pooled dataset giving the Integrative Data Analysis (IDA) needs. A similar approach applied to relational clinical databases is developed by Kock‐Schoppenhauer et al 40 Another work in Cancer studies is done by Mihaylov et al, 41 which presents an approach for the integration of data from diverse domains and various information sources enabling extraction of novel knowledge in cancer studies. The data used in the work consist of clinical records from two particular cancer studies with different factors and different origin, and also include gene expression datasets from high‐throughput technologies, microarray, and next‐generation sequencing.…”
Section: Related Workmentioning
confidence: 99%
“…It is Implemented upon the Ontop platform 39 and built a data integration pipeline to query, extract, and transform data in relational databases using semantic queries into a pooled dataset giving the Integrative Data Analysis (IDA) needs. A similar approach applied to relational clinical databases is developed by Kock‐Schoppenhauer et al 40 Another work in Cancer studies is done by Mihaylov et al, 41 which presents an approach for the integration of data from diverse domains and various information sources enabling extraction of novel knowledge in cancer studies. The data used in the work consist of clinical records from two particular cancer studies with different factors and different origin, and also include gene expression datasets from high‐throughput technologies, microarray, and next‐generation sequencing.…”
Section: Related Workmentioning
confidence: 99%